4.18 Dementia Interventions, Skills for Epidemiologists, & Aducanumab with Dr. Maria Glymour

Plenary Session

Vinay Prasad, MD MPH

Health, Medicine, Policy, Oncology, Science & Medicine

4.7 • 789 Ratings

🗓️ 1 September 2021

⏱️ 78 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Today we're joined by social epidemiologist, Dr. Maria Glymour of UCSF. We talk about her work in studying public health interventions for dementia and how her experience in academia has led to her conviction in the necessity of rigorous, quantitative technical skills training for epidemiology PhD students. We touch on how to have a good idea, her advice for PhD applicants, and working in a soft money (grants) vs hard money environment. Finally, we discuss her idea for a stepped-wedge trial approach to evaluate the new Alzheimer's drug, aducanumab. Aducanumab: https://sites.bu.edu/melodem/files/2021/07/Pragmatic-Study-Designs-to-Accelerate-Aducanumab-Evidence_Glymour.pdf Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to Plenary Session.
0:07.9	I'm Vinay Prasad. I'm an associate professor with University of California, San Francisco.
0:11.9	I'm a practicing he-mong doctor, and my interests are medicine, oncology, and health policy.
0:16.4	And that's what you're going to get on Plenary Session.
0:21.6	This is season four, hashtag zero COVID.
0:24.6	It's zero COVID because we're not going to talk about COVID.
0:26.6	We're back, oncology, medicine, health policy.
0:29.6	We've got a lot in store for you.
0:33.6	But first, a plug.
0:34.6	If you like this podcast, leave us a rating or write us a review. It helps new listeners find the show. You can follow us on Twitter at Plenary underscore Session. You can email us at plenary session podcast at gmail.com. Give us your suggestions on what we should be covering. And we got a new YouTube channel, Vinay Prasad, MDMPH. Follow us on YouTube. I'm putting up a 10-part series on reading and interpreting cancer clinical trials.
0:57.6	You'll want to watch it there.
1:00.3	And if you really love this show, you can back us on patreon.com.
1:04.1	Patreon backers get access to slides for lectures I give on Plenary Session.
1:08.3	And with that, let's start the show. I'm back in plenary session and I'm in the
1:13.7	real life edition. This is as real as it gets in this life. And I'm joined by the great Dr. Maria Glemore.
1:19.8	Dr. Gleymour is professor of epidemiology and biostatistics at the University of California, San Francisco.
1:23.9	She is the director of the PhD program, and she is an expert in causal inference
1:28.6	in cognitive dysfunction, Alzheimer's disease, and in many of the things that predispose one to that
1:34.4	many years in advance. And she's also a very thoughtful person at the intersection, I think,
1:38.0	of epidemiology and human health. So Dr. Glemore, it's a pleasure to have you here on this podcast.
1:42.9	Thanks. That's wonderful to be here. It's
1:44.6	actually quite surreal to see you when I'm used to listening to you, to like see the speech in real time.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Vinay Prasad, MD MPH, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Vinay Prasad, MD MPH and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.